PNNL researchers are contributing expertise and hydrothermal liquefaction technology to a project that intercepts harmful algal blooms from water, treats the water, and concentrates algae for transformation to biocrude.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
In a new review, PNNL researchers outline how to convert stranded biomass to sustainable fuel using electrochemical reduction reactions in mini-refineries powered by renewable energy.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
PNNL atomic-scale research shows how certain metal oxide catalysts behave during alkanol dehydration, an important class of oxygen-removal reactions for biomass conversion.
Biomedical scientist Brian Thrall co-edited the issue published in the journal NanoImpact. Three of the articles in the issue include multiple PNNL authors.
Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.
PNNL’s Karthikeyan Ramasamy was elected to a three-year term as a director in the American Institute of Chemical Engineers’ Fuels and Petrochemicals Division.
Jonathan Male originally joined PNNL in 2006 as a scientist focused on catalysis. After more than seven years leading DOE’s Bioenergy Technologies Office, he's back at PNNL as a chief scientist in the Energy Processes & Materials Division.
PNNL computational biologist Bobbie-Jo Webb-Robertson was recently awarded the “Spirit of nPOD award” to acknowledge her hard work in building, coordinating, and leading the Data Science Working Group.
To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.
PNNL biomedical scientist Ernesto Nakayasu brings expertise in host-pathogen interactions and the interconnection between the immune response and cellular metabolism to provide constructive review for submitted manuscripts.
After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.